O'Sullivan B, Mackillop W, Gilbert R, Gaze M, Lundgren J, Atkinson C, Wynne C, Fu H
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.
Radiother Oncol. 1994 Apr;31(1):23-32. doi: 10.1016/0167-8140(94)90410-3.
Cancer of the larynx is the most prevalent non-cutaneous malignancy of the head neck region and its treatment presents a threat to both natural speech and survival. This study examines the manner in which two separate specialties in the same and different geographic regions vary in their opinions about the treatment of glottic laryngeal cancer. The goal was to define options available to patients and to classify controversies about optimal treatment which might be resolved in clinical trials. Questionnaires depicting different presentations of glottic larynx cancer were mailed to 1649 otolaryngologists and radiation oncologists in North America, Europe and Australasia. Half the doctors were asked to describe their preferred treatment for a patient while the others were asked to imagine that they themselves were the patient. In all the disease situations opinions varied significantly with respect to the treatment modality advised (whether to employ surgical or radiotherapy approaches) and in more extensive disease situations the intention of treatment also varied depending on whether a curative approach should involve conservation or loss of the larynx. Doctors also recommended similar treatment for their patients as they would for themselves. Apart from disease extent the most significant variables influencing recommendations were the physicians' specialty (P = 0.0001) and where they practice (P = 0.0001). These findings demonstrate diversity of opinion which is influenced more profoundly by the traditions of the specialties and geographic location of practice than by the reported results of treatments for laryngeal cancer. Convictions about optimal management have become barriers to the assessment of the relative value of different treatments and to ensuring that patients are fully informed about management options. The profession should regard as a high priority efforts to resolve these therapeutic conflicts which are associated with major differences in quality of life.
喉癌是头颈部最常见的非皮肤恶性肿瘤,其治疗对自然发声和生存都构成威胁。本研究探讨了同一地理区域和不同地理区域的两个不同专业在声门型喉癌治疗意见上的差异方式。目的是确定患者可选择的治疗方案,并对关于最佳治疗的争议进行分类,这些争议可能在临床试验中得到解决。向北美、欧洲和澳大拉西亚的1649名耳鼻喉科医生和放射肿瘤学家邮寄了描述声门型喉癌不同表现的问卷。一半的医生被要求描述他们对一名患者的首选治疗方案,而另一半医生则被要求设想自己就是患者。在所有疾病情况下,对于建议的治疗方式(是否采用手术或放疗方法),意见存在显著差异;在病情更广泛的情况下,治疗意图也因根治性治疗应保留还是切除喉部而有所不同。医生为患者推荐的治疗方案与他们为自己推荐的相似。除了疾病范围外,影响建议的最显著变量是医生的专业(P = 0.0001)和他们的执业地点(P = 0.0001)。这些发现表明,意见的多样性更多地受到专业传统和执业地理位置的影响,而不是喉癌治疗报告结果的影响。对最佳治疗管理的信念已成为评估不同治疗相对价值以及确保患者充分了解治疗选择的障碍。该行业应将解决这些与生活质量重大差异相关的治疗冲突的努力视为高度优先事项。